In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure

نویسندگان

  • Yasunori Ueda
  • Koshi Matsuo
  • Yuji Nishimoto
  • Ryuta Sugihara
  • Akio Hirata
  • Takayoshi Nemoto
  • Masato Okada
  • Ayaka Murakami
  • Kazunori Kashiwase
  • Kazuhisa Kodama
چکیده

A lthough introduction of drug-eluting stent (DES) use substantially reduced early target lesion revascularization (TLR) as compared to bare-metal stent use by restricting development of neointima hyperplasia, DES have been associated with increased the risk of stent thrombosis and TLR after 1 year, that is, very late stent failure (VLSF) (1). The incidence of VLSF has been reduced with the use of newer DES than with first-generation DES (2–8), but VLSF remains an unresolved problem

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.

OBJECTIVES We sought to examine by angioscopy the neointima formation and thrombogenic potential of the neointima after deployment of a drug-eluting stent (DES). BACKGROUND Late stent thrombosis after DES implantation, a major safety concern, has been associated with poor strut coverage by neointima. Intracoronary angioscopy provides a method for visual evaluation of stent coverage by neointi...

متن کامل

Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial.

BACKGROUND Long-term clinical outcomes of everolimus-eluting stent (EES) compared with sirolimus-eluting stent (SES) have not been evaluated fully yet, especially whether EES implantation could positively affect late adverse events reported after SES implantation occurring >1 year. METHODS AND RESULTS In this all-comer prospective multicenter randomized open-label trial, 3196 patients were as...

متن کامل

Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised.

Late stent thrombosis (ST) made headlines when investigators realized that clinical events related to late ST, although rare, carried a mortality rate of up to 45% and a nonfatal infarction rate of another 30% to 40%.1,2 These rates clearly were more than those seen after bare metal stent (BMS) implantation, as first shown prospectively in the randomized Basel Stent Kosten Effektivitäts Trial–L...

متن کامل

Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.

BACKGROUND Stent thrombosis may occur late after drug-eluting stent (DES) implantation, and its cause remains unknown. The present study investigated differences of the stented segment between patients with and without very late stent thrombosis with the use of intravascular ultrasound. METHODS AND RESULTS Since January 2004, patients presenting with very late stent thrombosis (> 1 year) afte...

متن کامل

Coronary Aneurysm Occurring Late after Drug-Eluting Stent Implantation

Drug-eluting stents may affect the normal healing process of the vessel wall and the remodeling process and may lead to late stent malapposition (LSM). The known incidence of this phenomen originates from short-term angiographic follow-up studies. We describe a case report of very late stent malapposition and marked positive vessel remodeling 3 years after sirolimus-eluting coronary stent impla...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2017